Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Dexmedetomidine Infusion in Ambulatory Knee Arthroscopy
ChiCTR2400085837Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in knee sprain and meniscal tear (3 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoint: EuroQol EQ-5D score on postoperative day 1. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
knee sprainmeniscal tear
Beyond the preview
Go deeper on ChiCTR2400085837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085837.